Key facts
- This page summarizes Ryan OQuinn's Form 4 filing for CareMax, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Nov 2023, 16:44.
Ryan OQuinn - 17 Nov 2023 Form 4 Insider Report for CareMax, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 17 Nov 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Nov 2023, 16:44:47 UTC
- Prior SEC filing
- 12 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Meredith Longsworth, Esq., as attorney-in-fact for Ryan O'Quinn
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ryan OQuinn filed Form 4 for CareMax, Inc. on 21 Nov 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMAX
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +12,123
- Change %
- Price
- Shares after
- 12,123
- Date
- 17 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMAX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -12,123
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 Nov 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 12,123
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On November 17, 2023, the reporting person received shares of Class A Common Stock of the issuer in settlement of restricted stock units ("RSUs"), which vested on November 17, 2023.
Footnote F2
RSUs convert into shares of Class A Common Stock of the issuer on a one-for-one basis.
Footnote F3
On November 17, 2022, the reporting person was granted 12,123 RSUs that vested on November 17, 2023.